SDC1 and prostate carcinoma: Direct examination of the endosome-lysosome system revealed that there is increased syndecan-1 and reduced sortilin in high-grade prostate cancer, and mechanistic studies further linked the activity of these proteins to dysregulated endosome trafficking and a lipogenic phenotype associated with a higher metastatic propensity [8,14].